Skip to main content
. 2009 Jul 21;162(1):14–21. doi: 10.1016/j.jviromet.2009.07.001

Table 3.

Results obtained for shell vial, standard cell culture, ELISA, Directigen Flu A and QCM methods in comparison with RT-PCR.

Test No of specimens
Sensitivitye Specificityf PPVg NPVh
TPa TNb FPc FNd
Shell vial Influenza A 28 27 3 9 76 90 90 75
Influenza B 12 52 0 3 80 100 100 95



Cell culture Influenza A 30 30 0 7 81 100 100 81
Influenza B 15 52 0 0 100 100 100 100



ELISA Influenza A 25 30 0 12 68 100 100 71
Influenza B 9 52 0 6 60 100 100 90



Directigen Flu A Influenza A 13 30 0 24 35 100 100 56
Influenza B NA NA NA NA NA NA NA NA



QCM Influenza A 28 30 0 9 76 100 100 77
Influenza B 12 52 0 3 80 100 100 95



QCM (nanoparticles) Influenza A 30 30 0 7 81 100 100 95
Influenza B 13 52 0 2 87 100 100 96

A total of 67 nasal samples were compared with RT-PCR which was used as the reference method (gold standard).

Samples positive by shell vial, standard cell culture, ELISA, Directigen Flu A kit and QCM, but negative by RT-PCR, were considered FP. Samples that were identified by RT-PCR assays were considered as TP. Samples that were negative by shell vial, standard cell culture, ELISA, BD Directigen Flu A kit and QCM but positive by PCR were regarded as FN. A sample that was negative by RT-PCR was a TN.

a

TP, true-positives.

b

TN, true-negatives.

c

FP, false-positives.

d

FN, false-negatives.

e

Sensitivity = number of TP specimens/(number of TP + number of FN specimens) × 100.

f

Specificity = number of TN specimens/(number of TN specimens + number of FP specimens) × 100.

g

PPV (positive predictive value) = TP/(TP + FP) × 100.

h

NPV (negative predictive value) = TN/(TN + TN) × 100.

HHS Vulnerability Disclosure